NCT01919619 2024-12-03Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid MalignanciesM.D. Anderson Cancer CenterPhase 2 Completed41 enrolled 11 charts
NCT01729806 2018-04-11Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell LymphomaNational Cancer Institute (NCI)Phase 1 Completed32 enrolled